Revumenib (radiolabeled)

revumenib · Syndax Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Revumenib (radiolabeled), covering 2025-01-10 to 2025-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of Radiolabeled Revumenib in Adults With Acute Leukemia [Phase 1]